vs
MARAVAI LIFESCIENCES HOLDINGS, INC.（MRVI）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是MARAVAI LIFESCIENCES HOLDINGS, INC.的1.6倍（$78.6M vs $49.9M），MARAVAI LIFESCIENCES HOLDINGS, INC.净利率更高（-71.6% vs -178.3%，领先106.7%），Repay Holdings Corp同比增速更快（0.4% vs -11.8%），Repay Holdings Corp自由现金流更多（$23.2M vs $-24.9M），过去两年Repay Holdings Corp的营收复合增速更高（-1.3% vs -11.9%）
Maravai生命科学控股是一家全球化生命科学企业，专注于开发供应关键试剂、诊断产品及技术解决方案，服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域，客户覆盖全球相关科研、医疗和企业机构。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
MRVI vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.6倍
$49.9M
营收增速更快
RPAY
高出12.2%
-11.8%
净利率更高
MRVI
高出106.7%
-178.3%
自由现金流更多
RPAY
多$48.1M
$-24.9M
两年增速更快
RPAY
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.9M | $78.6M |
| 净利润 | $-35.7M | $-140.1M |
| 毛利率 | 25.8% | 74.2% |
| 营业利润率 | -117.9% | -182.2% |
| 净利率 | -71.6% | -178.3% |
| 营收同比 | -11.8% | 0.4% |
| 净利润同比 | -37.7% | -3304.1% |
| 每股收益（稀释后） | $-0.24 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRVIRPAY
| Q4 25 | $49.9M | $78.6M | ||
| Q3 25 | $41.6M | $77.7M | ||
| Q2 25 | $47.4M | $75.6M | ||
| Q1 25 | $46.9M | $77.3M | ||
| Q4 24 | $56.6M | $78.3M | ||
| Q3 24 | $69.0M | $79.1M | ||
| Q2 24 | $69.4M | $74.9M | ||
| Q1 24 | $64.2M | $80.7M |
净利润MRVIRPAY
| Q4 25 | $-35.7M | $-140.1M | ||
| Q3 25 | $-25.6M | $-6.4M | ||
| Q2 25 | $-39.6M | $-102.3M | ||
| Q1 25 | $-29.9M | $-7.9M | ||
| Q4 24 | $-25.9M | $-4.1M | ||
| Q3 24 | $-97.1M | $3.2M | ||
| Q2 24 | $-9.8M | $-4.1M | ||
| Q1 24 | $-12.1M | $-5.2M |
毛利率MRVIRPAY
| Q4 25 | 25.8% | 74.2% | ||
| Q3 25 | 13.6% | 74.4% | ||
| Q2 25 | 16.4% | 75.7% | ||
| Q1 25 | 16.5% | 75.9% | ||
| Q4 24 | 34.3% | 76.3% | ||
| Q3 24 | 46.7% | 77.8% | ||
| Q2 24 | 44.4% | 78.2% | ||
| Q1 24 | 40.3% | 76.2% |
营业利润率MRVIRPAY
| Q4 25 | -117.9% | -182.2% | ||
| Q3 25 | -98.6% | -3.9% | ||
| Q2 25 | -139.8% | -138.7% | ||
| Q1 25 | -104.9% | -4.7% | ||
| Q4 24 | -66.7% | -1.5% | ||
| Q3 24 | -239.9% | -0.9% | ||
| Q2 24 | -19.4% | -4.6% | ||
| Q1 24 | -29.4% | -3.1% |
净利率MRVIRPAY
| Q4 25 | -71.6% | -178.3% | ||
| Q3 25 | -61.4% | -8.3% | ||
| Q2 25 | -83.5% | -135.2% | ||
| Q1 25 | -63.9% | -10.3% | ||
| Q4 24 | -45.8% | -5.3% | ||
| Q3 24 | -140.6% | 4.1% | ||
| Q2 24 | -14.1% | -5.4% | ||
| Q1 24 | -18.8% | -6.5% |
每股收益（稀释后）MRVIRPAY
| Q4 25 | $-0.24 | $-1.68 | ||
| Q3 25 | $-0.18 | $-0.08 | ||
| Q2 25 | $-0.27 | $-1.15 | ||
| Q1 25 | $-0.21 | $-0.09 | ||
| Q4 24 | $-0.21 | $-0.04 | ||
| Q3 24 | $-0.68 | $0.03 | ||
| Q2 24 | $-0.07 | $-0.04 | ||
| Q1 24 | $-0.09 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9M | $115.7M |
| 总债务越低越好 | $291.8M | $280.1M |
| 股东权益账面价值 | $212.4M | $484.4M |
| 总资产 | $770.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.37× | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资MRVIRPAY
| Q4 25 | $216.9M | $115.7M | ||
| Q3 25 | $243.6M | $95.7M | ||
| Q2 25 | $269.9M | $162.6M | ||
| Q1 25 | $285.1M | $165.5M | ||
| Q4 24 | $322.4M | $189.5M | ||
| Q3 24 | $578.2M | $168.7M | ||
| Q2 24 | $573.2M | $147.1M | ||
| Q1 24 | $561.7M | $128.3M |
总债务MRVIRPAY
| Q4 25 | $291.8M | $280.1M | ||
| Q3 25 | $292.8M | $279.5M | ||
| Q2 25 | $293.9M | $279.0M | ||
| Q1 25 | $294.9M | $497.6M | ||
| Q4 24 | $295.9M | $496.8M | ||
| Q3 24 | $521.7M | $496.2M | ||
| Q2 24 | $522.5M | $435.6M | ||
| Q1 24 | $523.3M | $434.9M |
股东权益MRVIRPAY
| Q4 25 | $212.4M | $484.4M | ||
| Q3 25 | $245.4M | $616.9M | ||
| Q2 25 | $265.9M | $633.7M | ||
| Q1 25 | $300.6M | $755.7M | ||
| Q4 24 | $325.3M | $761.3M | ||
| Q3 24 | $344.9M | $754.7M | ||
| Q2 24 | $434.7M | $815.4M | ||
| Q1 24 | $410.7M | $813.8M |
总资产MRVIRPAY
| Q4 25 | $770.6M | $1.2B | ||
| Q3 25 | $849.2M | $1.3B | ||
| Q2 25 | $897.0M | $1.4B | ||
| Q1 25 | $959.8M | $1.5B | ||
| Q4 24 | $1.0B | $1.6B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $1.4B | $1.5B | ||
| Q1 24 | $1.4B | $1.5B |
负债/权益比MRVIRPAY
| Q4 25 | 1.37× | 0.58× | ||
| Q3 25 | 1.19× | 0.45× | ||
| Q2 25 | 1.11× | 0.44× | ||
| Q1 25 | 0.98× | 0.66× | ||
| Q4 24 | 0.91× | 0.65× | ||
| Q3 24 | 1.51× | 0.66× | ||
| Q2 24 | 1.20× | 0.53× | ||
| Q1 24 | 1.27× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.8M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-24.9M | $23.2M |
| 自由现金流率自由现金流/营收 | -49.9% | 29.6% |
| 资本支出强度资本支出/营收 | 4.2% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-70.7M | $90.7M |
8季度趋势，按日历期对齐
经营现金流MRVIRPAY
| Q4 25 | $-22.8M | $23.3M | ||
| Q3 25 | $-15.2M | $32.2M | ||
| Q2 25 | $-10.3M | $33.1M | ||
| Q1 25 | $-9.4M | $2.5M | ||
| Q4 24 | $-14.6M | $34.3M | ||
| Q3 24 | $13.1M | $60.1M | ||
| Q2 24 | $17.4M | $31.0M | ||
| Q1 24 | $-8.5M | $24.8M |
自由现金流MRVIRPAY
| Q4 25 | $-24.9M | $23.2M | ||
| Q3 25 | $-18.1M | $32.1M | ||
| Q2 25 | $-13.1M | $33.0M | ||
| Q1 25 | $-14.6M | $2.4M | ||
| Q4 24 | $-20.5M | $34.0M | ||
| Q3 24 | $4.5M | $59.8M | ||
| Q2 24 | $7.9M | $30.5M | ||
| Q1 24 | $-14.1M | $24.7M |
自由现金流率MRVIRPAY
| Q4 25 | -49.9% | 29.6% | ||
| Q3 25 | -43.4% | 41.3% | ||
| Q2 25 | -27.7% | 43.6% | ||
| Q1 25 | -31.2% | 3.0% | ||
| Q4 24 | -36.2% | 43.5% | ||
| Q3 24 | 6.6% | 75.6% | ||
| Q2 24 | 11.4% | 40.7% | ||
| Q1 24 | -22.0% | 30.6% |
资本支出强度MRVIRPAY
| Q4 25 | 4.2% | 0.1% | ||
| Q3 25 | 7.0% | 0.2% | ||
| Q2 25 | 6.1% | 0.1% | ||
| Q1 25 | 11.2% | 0.2% | ||
| Q4 24 | 10.3% | 0.3% | ||
| Q3 24 | 12.4% | 0.3% | ||
| Q2 24 | 13.8% | 0.6% | ||
| Q1 24 | 8.8% | 0.1% |
现金转化率MRVIRPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
